DNA-protective activities of hyperforin and aristoforin

Toxicology in Vitro

Volumn 29, Issue 3, 2015, Pages 631-637

  Sevcovicova A ^a   Semelakova M ^b   Plsikova J ^b   Loderer, D ^a   Imreova P ^a   Galova E ^a   Kozurkova M ^b   Miadokova E ^a   Fedorocko P ^b  

^a Faculty of Natural Sciences   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Aristoforin; DNA unwinding assay; DNA topology assay; DPPH OH scavenging activity; Hyperforin; Reducing power assay

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ARISTOFORIN; DNA; DNA TOPOISOMERASE; FERROUS ION; FREE RADICAL; HYPERFORIN; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; ANTIOXIDANT; DNA TOPOISOMERASE INHIBITOR; IRON; IRON CHELATING AGENT; PHLOROGLUCINOL; SCAVENGER; TERPENE;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA DETERMINATION; DNA STRAND BREAKAGE; DPPH RADICAL SCAVENGING ASSAY; DRUG ACTIVITY; DRUG DNA INTERACTION; ELECTROPHORESIS; FLUORESCENCE; HYDROXYL RADICAL SCAVENGING ASSAY; HYPERICUM PERFORATUM; PROTECTION; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; HYPERICUM;

HYPERICUM PERFORATUM;

ANTIOXIDANTS; DNA; DNA BREAKS; FREE RADICAL SCAVENGERS; HYPERICUM; IRON; IRON CHELATING AGENTS; PHLOROGLUCINOL; TERPENES; TOPOISOMERASE I INHIBITORS;

EID: 84923313188     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.01.016     Document Type: Article

References (44)

1. Ang C.Y., Hu L., Heinze T.M., Cui Y., Freeman J.P., Kozak K., Luo W., Liu F.F., Mattia A., DiNovi M. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage. J. Agric. Food Chem. 2004, 52:6156-6164.
2. Barceló F., Ortiz-Lombardía M., Martorell M., Oliver M., Méndez C., Salas J.A., Portugal J. DNA binding characteristics of mithramycin and chromomycin analogues obtained by combinatorial biosynthesis. Biochemistry 2010, 49:10543-10552.
3. Busa J. Octave 2006, Technical University, Košice.
4. Čipák L., Miadoková E., Dingová H., Kogan G., Novotný L., Rauko P. Comparative DNA protectivity and antimutagenicity studies using DNA-topology and Ames assays. Toxicol. In Vitro 2001, 15:677-681.
5. Cipak L., Grausova L., Miadokova E., Novotny L., Rauko P. Dual activity of triterpenoids: apoptotic versus antidifferentiation effects. Arch. Toxicol. 2006, 80:429-435.
6. Farvin K.H.S., Jacobsen C. Phenolic compounds and antioxidant activities of selected species of seaweeds from Danish coast. Food Chem. 2013, 138:1670-1681.
7. Gartner M., Müller T., Simon J.C., Giannis A., Sleeman J.P. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent. ChemBioChem 2005, 6:171-177.
8. Gioti E., Fiamegos Y., Skalkos D., Stalikas C. Antioxidant activity and bioactive components of the aerial parts of Hypericum perforatum L. from Epirus. Greece Food Chem. 2009, 117:398-404.
9. Gong B., Yan Y. New DNA minor-groove binding molecules with high sequence-selectivities and binding affinities. Biochem. Biophys. Res. Commun. 1997, 240:557-560.
10. Gordon M.H. The mechanism of the antioxidant action in vitro. Food Antioxidants 1990, 1-18. Elsevier, London/New York. J.F. Hudson (Ed.).
11. Gulcin I., Bursal E., Sehitoğlu M.H., Bilsel M., Gören A.C. Polyphenol contents and antioxidant activity of lyophilized aqueous extract of propolis from Erzurum, Turkey. Food Chem Toxicol. 2010, 48:2227-2238.
12. Horváthová E., Kozics K., Srančíková A., Hunáková L., Gálová E., Ševčovičová A., Slameňová D. Borneol administration protects primary rat hepatocytes against exogenous oxidative DNA damage. Mutagenesis 2012, 27:581-588.
13. Hu J., Geng G., Li Q., Sun X., Cao H., Liu Y. Effects of alginate on frozen-thawed boar spermatozoa quality, lipid peroxidation andantioxidant enzymes activities. Anim. Reprod. Sci. 2014, 147:112-118.
14. Huang D., Ou B., Prior R.L. The chemistry behind antioxidant capacity assays. Agric. Food Chem. 2005, 53:1841-1856.
15. Hudecová A., Hašplová K., Miadoková E., Magdolenová Z., Rinna A., Collins A.R., Gálová E., Vaculčíková D., Gregáň F., Dušinská M. Gentiana asclepiadea protects human cells against oxidation DNA lesions. Cell Biochem. Funct. 2012, 30:101-107.
16. Ihmels H., Otta D. Intercalation of organic dye molecules into double-stranded DNA - general principles and recent development. Curr. Chem. 2005, 258:161-204.
17. Jendželovská Z., Jendželovský R., Hiľovská L., Kovaľ J., Mikeš J., Fedoročko P. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatinand mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells. Toxicol. In Vitro 2014, 28:1259-1273.
18. Kozurková M., Sabolová D., Paulíková H., Janovec L., Kristian P., Bajdichová M., Busa J., Podhradský D., Imrich J. DNA binding properties and evaluation of cytotoxic activity of 9,10-bis-N-substituted (aminomethyl)anthracenes. Int. J. Biol. Macromol. 2007, 41:415-422.
19. Locatelli M., Gindro R., Travaglia F., Coisson J.D., Rinaldi M., Arlorio M. Study of the DPPH-scavenging activity: development of a free software for the correct interpretation of data. Food Chem. 2009, 114:889-897.
20. Loontiens F.G., Regenfuss P., Zechel A., Dumortier L., Clegg R.M. Binding characteristics of Hoechst 33258 with calf thymus DNA, poly[d(A-T)], and d(CGCGAATTCGCG): multiple stoichiometries and determination of tight binding with a wide spectrum of site affinities. Biochemistry 1990, 29:9029-9039.
21. McGhee J.D., von Hippel P.H. Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J. Mol. Biol. 1974, 86:469-489.
22. McKnight R.E., Gleason A.B., Keyes J.A., Sahabi S. Binding mode and affinity studies of DNA-binding agents using topoisomerase I DNA unwinding assay. Bioorg. Med. Chem. Lett. 2007, 17:1013-1017.
23. Meinke M.C., Schanzer S., Haag S.F., Casetti F., Müller M.L., Wölfle U., Kleemann A., Lademann J., Schempp C.M. In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo. Eur. J. Pharm. Biopharm. 2012, 81:346-350.
24. Miadoková E., Svidová S., Vlčková V., Dúhová V., Naďová S., Rauko P., Kogan G. Diverse biomodulatory effects of glucomannan from Candida utilis. Toxicol. In Vitro 2006, 20:649-657.
25. Moon Y.J., Wang X., Morris M.E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 2006, 20:187-210.
26. Naithani V., Singhal A.K., Chaudhary M. Comparative evaluation of metal chelating, antioxidant and free radical scavenging activity of TROIS and six products commonly used to control pain and inflammation associated with Arthritis. Int. J. Drug Dev. Res. 2011, 3:208-216.
27. Nitiss J.L. Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 2009, 9:338-350.
28. Orta M.L., Mateos S., Cantero G., Wolff L.J., Cortés F. Protection of halogenated DNA from strand breake and sister-chromatid exchange by topoisomerase I Inhibitor camptothecin. Mutat. Res. 2008, 637:40-48.
29. Orth H.C.J., Rentel C., Schmidt P.C. Isolation, purity analysis and stability of hyperforin as a standard material from Hypericum perforatum L. J. Pharm. Pharmacol. 1999, 51:193-200.
30. Pandya P., Islam M.M., Kumar G.S., Jayaram B., Kumar S. DNA minor groove binding of small molecules: experimental and computational evidence. J. Chem. Sci. 2010, 122:247-257.
31. Plsikova J., Janovec L., Koval J., Ungvarsky J., Mikes J., Jendzelovsky R., Fedorocko P., Imrich J., Kristian P., Kasparkova J., Brabec V., Kozurkova M. 3,6-Bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents. Eur. J. Med. Chem. 2012, 57:283-295.
32. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 2006, 6:789-802.
33. Pommier Y. DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition. Chem. Rev. 2009, 109:2894-2902.
34. Quiney C., Billard C., Salanoubat C., Fourneron J.D., Kolb J.P. Hyperforin, a new lead compound against the progression of cancer and leukemia?. Leukemia 2006, 20:1519-1525.
35. 2+ chelating activity. Acta Pharm. 2010, 60:325-337.
36. Rauko P., Romanova D., Miadokova E., Macakova K., Novotny L., Elford H.L., Szekeres T. DNA-protective activity of new ribonucleotide reductase inhibitors. Anticancer Res. 1997, 17:3437-3440.
37. Semelakova M., Mikes J., Jendzelovsky R., Fedorocko P. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells. J. Photochem. Photobiol. B: Biol. 2012, 117:115-125.
38. Stohs S.J., Bagchi D. Oxidative mechanism in the toxicity of metal ions. Free Radic. Biol. Med. 1995, 18:321-336.
39. Wang L., Eastmond D.A. Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187. Environ. Mol. Mutagen. 2002, 39:348-356.
40. Wang H., Gao X.D., Zhou G.C., Cai L., Yao W.B. In vitro and in vivo antioxidant activity of aqueous extract from Choerospondias axillaris fruit. Food Chem. 2008, 106:888-895.
41. Wang P., Rennekamp A.J., Yuan Y., Lieberman P.M. Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation. J. Virol. 2009, 83:8090-8098.
42. Wanunu M., Tor Y. Methods for Studying Nucleic Acid/Drug Interactions 2012, CRC Press, (Taylor and Francis Group), Baca Raton, FL.
43. Webb M.R., Ebeler S.E. A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation. Anal. Biochem. 2003, 321:22-30.
44. 2 dyade structure. Appl. Catal. B 2012, 111-112:303-308.